Novo Nordisk A/S · Bagsværd Denmark ·(NYSE: NVO)(OMX Copenhagen: NOVO B)
Company Description
Phone: +45-4444-8888
Fax: +45-4449-0555
Rankings
- #166 in FT Global 500
View Novo Nordisk A/S Locations On A US Map
This link will open in a new window
This link will open in a new window Novo Nordisk gives diabetics the tools to stick it to their disease. One of the world's leading producers of insulin, Novo Nordisk also makes insulin analogues, injection devices, and diabetes education materials. Its products include analogues Levemir and NovoRapid (which mimic natural insulin regulation more closely than human insulin) and the FlexPen, a pre-filled insulin injection tool. In addition to its diabetes portfolio, the firm has products in the areas of hemostasis management (blood clotting), human growth hormone, and hormone replacement therapy. The not-for-profit Novo Nordisk Foundation, through its Novo A/S subsidiary, controls the voting power in Novo Nordisk. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Novo Nordisk A/S Executives
59 executives listed for Novo Nordisk A/S's Bagsværd, location.
| Title | Name & Bio | Contact |
| Chairman | Sten Scheibye | Network |
| Vice Chairman | Goron Ando | Network |
| President and CEO | Lars Rebien Sørensen | Network |
Competition
Competitive Landscape for Novo Nordisk A/S
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top Novo Nordisk A/S Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!